Saurab Jain
10 Aug • 12:07 PM · SEBI-Registered Analyst
SBI Strong Fundamentals Support Growth Momentum
Krebs Biochemicals & Industries Ltd. share price is currently ₹51.52, down by - ₹5.13 (9.06%) from its previous closing price of ₹56.65. The share price has declined -8% over the past month and declined -26.35% over the past year. The stock's 52-week low and high are ₹37.74 and ₹75.88, respectively. Krebs Biochemicals & Industries Ltd. has a market capitalisation of ₹ 130.00 Cr. The share price was last updated on 23 Oct 2026, 03:29 PM IST.

Updated: 23 Oct 2026, 03:29:29 pm IST

Corporate Actions will be available shortly.
Mutual Fund Ownership will be available shortly.Krebs Biochemicals & Industries Ltd is an India-based company, which is engaged in the business of manufacture of active pharmaceutical ingredients. The Company manufactures bulk active pharmaceutical ingredients, pharmaceutical intermediates, fine chemicals, nutraceuticals utilizing two revenue streams: contract manufacturing for large pharmaceutical and multinational companies, and development of its products for sale in global markets. Its products include Androstenedione, Lovastatin, and Simvastatin. The Company's pilot or research and development stages products are Amlodipine, Cetirizine, Orlistat, Serratiopepetidase, Telmisartan, and Phenylephrine. The Company has two manufacturing facilities one at Regadichelaka, Nellore District and another one at Kothapalli Village, Kasimkota Mandal, Visakhapatnam District, Andhra Pradesh, India.
Insights from SEBI-registered analysts · updated live
Today's market leaders and laggards
Steel Strips Wheels Ltd.
SSWL
₹467.13
+80.51 (20.82%)
Linc Ltd.
LINC
₹87.43
+11.10 (14.54%)
Antelopus Selan Energy Ltd.
ANTELOPUS
₹1,118.67
+121.64 (12.20%)
JSW Dulux Ltd.
JSWDULUX
₹283.30
+27.43 (10.72%)
Shree Rama Multi-Tech Ltd.
SHREERAMA
₹58.14
+5.34 (10.11%)